Vivos (RDGL) EBITDA Margin Growth (5y) (2016 - 2025)
Vivos (RDGL) EBITDA Margin Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.86 Bn | 175.56 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.31 Bn | 99.09 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.25 Bn | 44.58 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.05 Bn | 25.76 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Vivos | 27.62 Mn | 26.06 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2.64 Mn |
| Dec 31, 2024 | 838,762.00 |
| Sep 30, 2024 | -927,281.00 |
| Mar 31, 2022 | 324,648.00 |
| Sep 30, 2021 | 1.51 Mn |
| Sep 30, 2020 | 60,260.00 |
| Mar 31, 2017 | -750,014.00 |
| Sep 30, 2016 | -1.55 Mn |
| Jun 30, 2016 | -7.90 Mn |
| Mar 31, 2016 | -1.64 Mn |